Implementing new guidelines would increase screening eligibility and detection of diabetes and prediabetes, according to an analysis published in JAMA. Screening, prevention and treatment of diabetes ...
You’ve just had your annual blood test, and your doctor gives you the news: You have prediabetes. Before you panic, know that the condition is very common. According to the Centers for Disease Control ...
Current medical guidelines recommend that people in a preliminary stage of type 2 diabetes lose at least 7 percent of their body weight in order to prevent manifest diabetes. In an article in Nature ...
Prediabetes, often known as borderline diabetes, is often reversible through consistent dietary and lifestyle changes.
November is American Diabetes Month®, a time to raise awareness about diabetes and join together in the work for a cure. Diabetes is one of the fastest growing chronic diseases in the world. Nearly ...
About The Study: The U.S. Preventive Services Task Force (USPSTF) and the American Diabetes Association (ADA) recently recommended lowering the starting age for diabetes screening to 35 to facilitate ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase its expanding focus on Dexcom CGM ...
Even prediabetes seemed to spell bad news for heart health, according to a national inpatient sample study. Prediabetes -- defined as an Hba1c between 5.7% to 6.4% -- among hospitalized patients was ...
An estimated 86 million people in the United States have prediabetes, but they typically have no symptoms. The long-term medical and economic complications of diabetes are significant, costing the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Recommendations for first-line therapy and comorbidities ...
Prediabetes, as defined by the International Expert Committee (IEC) (A1c 6.0% to < 6.5%), was associated with significantly increased risk for major adverse cardiovascular events (MACE) compared with ...
The revised ADA guidelines state that 2 large clinical trials justify consideration of empagliflozin or liraglutide in patients with established cardiovascular disease to reduce the risk of death. ADA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback